Lasofoxifene
- Generic Name
- Lasofoxifene
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C28H31NO2
- CAS Number
- 180916-16-9
- Unique Ingredient Identifier
- 337G83N988
- Background
Lasofoxifene is a non-steroidal 3rd generation selective estrogen receptor modulator (SERM) that selectively binds to both ERα and ERβ with high affinity. It is a naphthalene derivative marketed for prevention and treatment of osteoporosis and for the treatment of vaginal atrophy. It was initially developed as Oporia by Pfizer as a treatment for postmenopaus...
- Indication
Investigated for use/treatment in postmenopausal osteoporosis to reduce the risk of both vertebral and novertebral fractures, as well as address other postmenopausal conditions, including reduction in risk of breast cancer and treatment of vulvar and vaginal atrophy (VVA)
- Associated Conditions
- -
- Associated Therapies
- -
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.